Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials.
- 2022-02-16
- Meta-Analysis
- Frontiers in public health 10
- Jia Yao
- Yuan Zhang
- Xian-Zhe Wang
- Jia Zhao
- Zhao-Jun Yang
- Yu-Ping Lin
- Lu Sun
- Qi-Yun Lu
- Guan-Jie Fan
- PubMed: 35252093
- DOI: 10.3389/fpubh.2022.814669
- High evidence
- Clinical
In COVID-19, the flavonoids group decreased the time taken for alleviation of symptoms, time taken for SARS-CoV-2 RT-PCR clearance, the RT-PCR positive subjects at day 7, time to achievement of the normal status of symptoms, patients needed oxygen, patients hospitalized and requiring mechanical ventilation, patients in ICU, days of hospitalization, and mortality vs. the control group.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes